Takeda Pharma FY21 Core Profit Rises

Takeda Pharmaceutical Company Limited (TKPHF.PK,TAK) reported fiscal 2021 core net profit of 663.7 million yen, an increase of 1.3% from prior year. Core earnings per share was 425 yen, up 1.2%.

Fiscal 2021 net profit was 230.1 million yen, a decline of 38.8%. Profit per share was 147 yen, down 38.9%.

Fiscal 2021 core revenue was 3.42 trillion yen, an underlying increase of 7.4%.

In FY2022, Takeda expects continued revenue growth. Core operating profit is expected to reach 1.1 trillion yen, mainly driven by business momentum.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Integrated energy company Chevron reported Friday that profit for the fourth quarter increased 25 percent from last year, reflecting 17 percent revenue growth amid higher realizations and higher margins on refined product sales. Adjusted earnings per share missed analysts' estimates, while quarterly revenues topped it. Reno, Nevada-based ZLINE Kitchen and Bath has expanded its recall of gas ranges citing serious risk of injury or death from carbon monoxide poisoning, the U.S. Consumer Product Safety Commission announced. The recall now includes about 30,000 units of ZLINE gas ranges, including about 28,000 units... The Food and Drug Administration's independent advisory committee unanimously recommended replacing the current original COVID vaccines used in the U.S. for primary shots with new bivalent omicron shots authorized as boosters, reports said. The committee also considered the proposal for annual COVID vaccination, however, didn't vote on it.
Follow RTT